Opening book details…
About this Medicine article
OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL by Evans, Kathryn; Duan, JianXin; Pritchard, Tara; Jones, Connor D; McDermott, Lisa; Gu, Zhaohui; Toscan, Cara E; El-Zein, Narimanne; Mayoh, Chelsea; Erickson, Stephen W; Guo, Yuelong; Meng, Fanying; Jung, Donald; Rathi, Komal S; Roberts, Kathryn G; Mullighan, Charles G.; Shia, Chi-Sheng; Pearce, Tillman; Teicher, Beverly A; Smith, Malcolm A.; Lock, Richard B is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Evans, Kathryn; Duan, JianXin; Pritchard, Tara; Jones, Connor D; McDermott, Lisa; Gu, Zhaohui; Toscan, Cara E; El-Zein, Narimanne; Mayoh, Chelsea; Erickson, Stephen W; Guo, Yuelong; Meng, Fanying; Jung, Donald; Rathi, Komal S; Roberts, Kathryn G; Mullighan, Charles G.; Shia, Chi-Sheng; Pearce, Tillman; Teicher, Beverly A; Smith, Malcolm A.; Lock, Richard B
- Publisher
- American Association for Cancer Research; American Association for Cancer Research (AACR) (ISSN 1078-0432)
- Published
- 2019
- Field
- Medicine (Health Sciences)